Cauldron Molecules
Cauldron Molecules is an Australian B2B contract manufacturer using proprietary continuous hyper-fermentation technology to scale precision fermentation for synthetic biology companies producing food, feed, cosmetic, and industrial bio-based ingredients.
- Company typePrivate
- Founded2022
- HeadquartersBorenore, Australia
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Cauldron Molecules does
Cauldron Molecules (operating commercially as Cauldron Ferm) is an Australian contract development and manufacturing organization (CDMO) specializing in precision fermentation for synthetic biology companies. Founded in 2022 in Orange, NSW, the company commercializes a proprietary continuous "hyper-fermentation" technology acquired from Agritechnology, which had developed continuous fermentation processes over more than 35 years. The technology addresses two historical barriers to continuous bioprocessing — contamination and genetic drift — by combining purpose-built ACE (defined-nutrient) media formulations with proprietary bioprocess protocols that have demonstrated continuous operation at 10,000-liter scale for over eight months without contamination or genetic drift.
Cauldron monetizes this capability through a three-tier B2B service model: FermaFit (technology transfer and lab-scale evaluation at 2L–150L), FermaValidate (scale-up to 10kL with techno-economic analysis), and FermaGrow (planned commercial-scale production at 100kL+). Its target customers are synthetic biology companies commercializing animal-free food proteins, dairy and egg proteins, alternative fats, cosmeceuticals, nutraceuticals, bio-based chemicals, materials, and specialty ingredients including animal feed and spider silk. The company claims its platform reduces customer cost of goods by 30–50% and requires 45% less capex than traditional fed-batch fermentation mega-facilities.
As of 2024, Cauldron operates from its food-grade Orange, NSW facility (R&D lab plus a 25,000-liter demo plant with two 10kL lines and downstream processing) and reports six contracted clients, with Nourish Ingredients as its first customer in 2023. The company is in the process of expanding to a planned 1,000+ tonne/year Cauldron Bio-fab in Mackay, Queensland (backed by Queensland Government Industry Partnership Program support) and a U.S. commercial-scale facility (backed by a $1.76M U.S. Department of Defense award). Total disclosed funding is approximately $26M across a 2023 seed round, a March 2024 Series A, and a March 2026 Series A2, plus non-dilutive Australian and U.S. government grants.
Cauldron Molecules firmographics
Firmographics- Name
- Cauldron Molecules
- Legal name
- Cauldron Molecules Pty Ltd
- Website
- https://cauldronferm.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Cauldron Molecules is an Australian B2B contract manufacturer using proprietary continuous hyper-fermentation technology to scale precision fermentation for synthetic biology companies producing food, feed, cosmetic, and industrial bio-based ingredients.
- Ownership category
- akta.pro rank
Cauldron Molecules industry classification
Industry- Product category
- Contract Biomanufacturing
- NAICS
- Food Manufacturing (311)
- SIC
- Beverages (2080)
- akta.pro primary industry
- Biological Formulation, Fermentation & Scale-Up Manufacturing (AFABAEAM)
- akta.pro secondary industry
- Fermentation Nutrients & Media (Yeast Extracts, Peptones, Nitrogen Sources, Minerals) (AFAJAJAH)
Keywords
Where Cauldron Molecules is headquartered
LocationHeadquarters
- HQ city
- Borenore
- HQ country
- Australia
- HQ region
- Oceania
Offices3 records
Markets served
Cauldron Molecules business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Technology or R&D, Operations, Personnel, Infrastructure, Supply Chain
Revenue model
- Contract Manufacturing Services: Cauldron provides specialized biomanufacturing as a service through a three-tier service model: FermaFit (technology transfer and evaluation), FermaValidate (scale-up to 10kL), and FermaGrow (commercial-scale production). Revenue is generated through service fees for fermentation manufacturing, with pricing likely based on volume, duration, and technical requirements.
- Technology Licensing (via acquisition of Agritechnology IP): Cauldron acquired Agritechnology's precision fermentation IP through its seed round in 2023 to commercialize and scale the technology globally. This proprietary technology forms the basis of their manufacturing services.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels4 records
Cauldron Molecules product offering
Product offeringCore offering
Cauldron Molecules provides contract biomanufacturing services using proprietary hyper-fermentation technology for precision fermentation companies developing bio-based food, feed, fibre, cosmetic, and industrial ingredients. The company operates a three-tier service model—FermaFit (technology transfer and lab-scale evaluation), FermaValidate (10kL scale validation and techno-economic analysis), and FermaGrow (commercial-scale production)—enabling clients to scale bio-based products from laboratory through to commercial volumes.
Product overview
Cauldron offers a biomanufacturing-as-a-service platform centered on its proprietary hyper-fermentation technology. The three-stage service pathway consists of FermaFit (technology transfer and lab-scale evaluation), FermaValidate (10kL scale optimization and techno-economic validation), and FermaGrow (commercial-scale production with hyper-fermentation). This platform targets precision fermentation companies across food proteins, functional ingredients and nutrition, cosmetics, materials, chemicals, and fuels sectors.
Differentiator
Problem solved
Functional benefit
Products and services
- FermaFit Technology transfer and evaluation service that transfers customer technology while protecting their intellectual property, rapidly assesses compatibility with ACE media, and confirms technical fit with Cauldron's hyper-fermentation platform at lab scale (2L-150L). Designed for precision fermentation companies seeking initial validation of their microbial strains and processes.
- FermaValidate Transition to 10kL scale service that optimizes hyper-fermentation conditions and processes to maximize productivity, validates conditions at 10,000L scale, and provides techno-economic analysis projecting output and cost of goods for hyper-fermentation at 100kL scale. Designed for clients ready to validate scaling economics.
- FermaGrow Commercial-scale production service using hyper-fermentation to achieve low-cost production, deliver commercial volumes at price parity with conventional products, and de-risk the path to commercialization for mainstream bioproducts. Designed for clients ready for commercial-scale manufacturing at 100kL+ scale.
Quantifiable outcome
- 30-50% reduction in cost of goods vs. traditional batch fermentation
- +5 more outcomes
Companies that use Cauldron Molecules
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles2 records
Cauldron Molecules technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Cauldron Molecules partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and foundational.
- Queensland GovernmentcoreQueensland Government supports Cauldron's development of the Cauldron Bio-fab in Mackay through its Industry Partnership Program (IPP). Aligns with Queensland's new-industry development strategy to develop industries in demand as the world decarbonizes.
- Boston BioprocesscorePartnership to help fermentation-based companies scale from lab to manufacturing. Boston Bioprocess brings best-in-class process development capabilities while Cauldron provides manufacturing expertise and hyper-fermentation technology. Together they aim to overcome the 'valley of death' for biotech companies transitioning from lab to commercial scale.
- Mackay BioFutures HubcoreQueensland BioHub project as part of a $300 million initiative to tap into the worldwide bioeconomy industry expected to be worth $700 billion by 2040. Project aims to turn traditional cane farming regions into biomanufacturing hubs.
- UNSW Founders 10x AcceleratorfoundationalAccelerator program that helped ignite Cauldron's trajectory, contributing to their $10.5M seed round which was the second-largest female-led seed round in Australian history.
Scale indicators10 records
Recent moves9 records
Expansion highlights6 records
Cauldron Molecules competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Cauldron Molecules compliance and trust
Trust signalCompliance4 records
Cauldron Molecules financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cauldron Molecules leadership team
Management profileNumber of profiles
Profiles4 records
Cauldron Molecules funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cauldron Molecules M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cauldron Molecules
What does Cauldron Molecules do?
Cauldron Molecules provides contract biomanufacturing services using proprietary hyper-fermentation technology for precision fermentation companies developing bio-based food, feed, fibre, cosmetic, and industrial ingredients. The company operates a three-tier service model—FermaFit (technology transfer and lab-scale evaluation), FermaValidate (10kL scale validation and techno-economic analysis), and FermaGrow (commercial-scale production)—enabling clients to scale bio-based products from laboratory through to commercial volumes.
Is Cauldron Molecules a public or private company?
Cauldron Molecules is a private company. It is classified as venture growth investor backed and is currently operating.
When was Cauldron Molecules founded?
Cauldron Molecules was founded in 2022. It employs 11 to 50 people.
Where is Cauldron Molecules based?
Cauldron Molecules is headquartered in Borenore, Australia, in the Oceania region.
How does Cauldron Molecules make money?
Two revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are technology Licensing (via acquisition of Agritechnology IP).
Does Cauldron Molecules have an API?
No public API is recorded for Cauldron Molecules.
What industry is Cauldron Molecules in?
Cauldron Molecules's product category is Contract Biomanufacturing. Its primary akta.pro industry code is AFABAEAM, Biological Formulation, Fermentation & Scale-Up Manufacturing, with a secondary code of AFAJAJAH, Fermentation Nutrients & Media (Yeast Extracts, Peptones, Nitrogen Sources, Minerals). Its NAICS code is 311 and its SIC code is 2080.